PCM
BSX icon

Pennant Capital Management’s Boston Scientific BSX Stock Holding History

Pennant Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,909,834
Closed -$72.1M – 39
2015
Q4 		$72.1M Sell
3,909,834
-958,900
-20% -$17.2M 1.83% 28
2015
Q3 		$79.9M Buy
4,868,734
+1,323,734
+37% +$22.6M 1.69% 26
2015
Q2 		$62.7M Buy
3,545,000
+665,000
+23% +$11.9M 1.25% 29
2015
Q1 		$51.1M Buy
+2,880,000
New +$45.5M 0.96% 31

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Pennant Capital Management's BSX Position: Q1 2016 in Review

Pennant Capital Management sold out of Boston Scientific (BSX) in Q1 2016, closing a stake of 3,909,834 shares — an estimated $72.1M sold.

Pennant Capital Management first reported a position in BSX in Q1 2015 and held it in 4 quarters. The position peaked at $79.9M in Q3 2015. 493 funds tracked by Wall St. Rank hold BSX as of Q1 2016.

  • Pennant Capital Management reported no remaining Boston Scientific position as of Q1 2016 after selling out during the quarter.
  • Pennant Capital Management sold 3,909,834 Boston Scientific shares in Q1 2016, an estimated $72.1M.
  • Pennant Capital Management first reported a position in Boston Scientific in Q1 2015 and held it in 4 quarters.
  • Pennant Capital Management's Boston Scientific position peaked at $79.9M in Q3 2015.
  • 493 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2016.

Based on Pennant Capital Management's 13F filing for Q1 2016, filed 16 May 2016.